Landmark UFO documents smuggled out of Russia 30 years ago — and just publicly revealed — show the Soviets investigated thousands of reports of extraterrestrial craft and encounters with aliens.

This local biotech says it has found a way to trick cancer cells into destroying themselves with its molecular glue. Now it's putting that claim to the test. After attracting global attention from ...

NEO-811 is a novel molecular glue degrader intended to fully block a key clear cell renal cell carcinoma signaling pathway via cereblon-dependent target degradation. The primary outcome measures for ...

This local biotech says it has found a way to trick cancer cells into destroying themselves with its molecular glue. Now it’s putting that claim to the test. After attracting global attention from ...

SAN DIEGO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Neomorph, Inc., a biotechnology company pioneering molecular glue degraders to address previously undruggable proteins, today announced the first patient ...

Neomorph, a San Diego biotech player, has treated its first patient in a first-in-human trial of NEO‑811, an experimental "molecular glue" meant to trigger the destruction of a protein that fuels ...